ZA917003B - Novel thiazolidine derivatives - Google Patents

Novel thiazolidine derivatives

Info

Publication number
ZA917003B
ZA917003B ZA917003A ZA917003A ZA917003B ZA 917003 B ZA917003 B ZA 917003B ZA 917003 A ZA917003 A ZA 917003A ZA 917003 A ZA917003 A ZA 917003A ZA 917003 B ZA917003 B ZA 917003B
Authority
ZA
South Africa
Prior art keywords
thiazolidine derivatives
novel thiazolidine
novel
derivatives
thiazolidine
Prior art date
Application number
ZA917003A
Other languages
English (en)
Inventor
Jan Bron
Bron Jan
Geert Jan Sterk
Jan Sterk Geert
Jan Fetze Van Der Werf
Fetze Van Der Werf Jan
Hendrik Timmerman
Timmerman Hendrik
Original Assignee
Cedona Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedona Pharm Bv filed Critical Cedona Pharm Bv
Publication of ZA917003B publication Critical patent/ZA917003B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA917003A 1990-09-05 1991-09-04 Novel thiazolidine derivatives ZA917003B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9001955A NL9001955A (nl) 1990-09-05 1990-09-05 Nieuwe thiazolidinederivaten.

Publications (1)

Publication Number Publication Date
ZA917003B true ZA917003B (en) 1993-04-28

Family

ID=19857632

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA917003A ZA917003B (en) 1990-09-05 1991-09-04 Novel thiazolidine derivatives

Country Status (12)

Country Link
US (1) US5385922A (xx)
EP (1) EP0547104A1 (xx)
JP (1) JPH06500318A (xx)
AU (1) AU656146B2 (xx)
CA (1) CA2089256A1 (xx)
FI (1) FI94754C (xx)
IE (1) IE913103A1 (xx)
IL (1) IL99393A0 (xx)
NL (1) NL9001955A (xx)
NZ (1) NZ239649A (xx)
WO (1) WO1992004337A1 (xx)
ZA (1) ZA917003B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2680173A1 (fr) * 1991-08-07 1993-02-12 Hoechst Lab Nitrates organiques, leurs procedes de preparation et leur utilisation dans le traitement de maladies cardiovasculaires .
JPH08507773A (ja) * 1993-03-15 1996-08-20 ビイク ネダーラント ベスローテン フェンノートシャップ 病的に高い眼圧の処置のための置換硝酸アルキルの使用
WO1995013811A1 (de) * 1993-11-17 1995-05-26 Byk Nederland Bv Verwendung substituierter thiazolidinderivate zur behandlung von erhöhtem augeninnendruck
JPH09507672A (ja) * 1994-01-19 1997-08-05 ビイク ネダーラント ベスローテン フェンノートシャップ ニトロキシ基含有ベンジルアミン誘導体及び循環器疾患並びに眼内圧増加の治療のためのその使用
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
AU2230897A (en) * 1996-03-01 1997-09-16 Sankyo Company Limited Thiazolidine derivatives
US6083966A (en) 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
NZ509172A (en) * 1998-09-21 2004-02-27 Univ Florida Antimalarial agents
ES2142773B1 (es) 1998-10-07 2001-01-01 Lacer Sa Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
WO2005034949A1 (en) * 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
DK1866296T3 (en) 2005-04-04 2017-02-13 Univ Florida DESFERRITHIOCINPOLYETHER-ANALOGS
BRPI0809077A2 (pt) * 2007-03-15 2014-09-09 Univ Florida Res Foudantion Inc Análogos de poliéter de desferritiocina
EP2149576A1 (en) 2008-07-22 2010-02-03 Lacer, S.A. Isosorbide Nitrates having vasodilating activity
CN102146062B (zh) * 2011-01-19 2013-04-24 山东大学 噻唑烷类神经氨酸酶抑制剂及其应用
CN103687843B (zh) 2011-10-24 2016-11-16 尼科斯科学爱尔兰公司 醌基一氧化氮供体化合物
US20140343110A1 (en) 2011-12-16 2014-11-20 University Of Florida Research Foundation, Inc. Uses of 4'-desferrithiocin analogs
RU2526619C2 (ru) * 2012-12-12 2014-08-27 Федеральное государственное бюджетное учреждение науки Институт высокомолекулярных соединений Российской академии наук Способ получения (2r,4r)-2-алкил-3-(2-меркаптобензоил)-1,3-тиазолидин-4-карбоновых кислот
AU2014233168B2 (en) * 2013-03-15 2018-11-22 Cancer Research Technology, Llc Methods and compositions for Gamma-glutamyl cycle modulation
WO2014169976A1 (en) 2013-04-18 2014-10-23 Nicox Science Ireland Quinone based nitric oxide donating compounds
EP3071201A4 (en) 2013-11-22 2017-04-26 University of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
CA2984250A1 (en) 2015-04-27 2016-11-03 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof
CN109516933B (zh) * 2018-10-29 2021-03-02 安徽省庆云医药股份有限公司 一种西洛多辛中间体的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58109461A (ja) * 1981-12-24 1983-06-29 Kowa Co 新規ベンズアミド誘導体
DE3248548A1 (de) * 1982-12-29 1984-07-05 Heinrich Mack Nachf., 7918 Illertissen Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3427241A1 (de) * 1984-07-24 1986-02-06 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verwendung derselben und diese enthaltende arzneimittel
DE3433383A1 (de) * 1984-09-12 1986-03-20 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phenyl-acetonitril-derivate
JPS6289662A (ja) * 1985-06-14 1987-04-24 Sankyo Co Ltd １，４−ジヒドロピリジン誘導体
IT1223565B (it) * 1987-12-21 1990-09-19 Zambon Spa Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica
US5025001A (en) * 1988-06-15 1991-06-18 Brigham And Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
NL8802276A (nl) * 1988-09-15 1990-04-02 Cedona Pharm Bv Geneesmiddel met relaxerende werking, dat als aktieve stof een nitraatester bevat.
JP2628756B2 (ja) * 1988-09-15 1997-07-09 シュバルツファルマ アクチェンゲゼルシャフト 新規有機ニトレート及びそれらの製造方法

Also Published As

Publication number Publication date
FI94754B (fi) 1995-07-14
IE913103A1 (en) 1992-03-11
CA2089256A1 (en) 1992-03-06
IL99393A0 (en) 1992-08-18
NL9001955A (nl) 1992-04-01
US5385922A (en) 1995-01-31
AU8400691A (en) 1992-03-30
EP0547104A1 (en) 1993-06-23
AU656146B2 (en) 1995-01-27
FI930723A0 (fi) 1993-02-18
FI94754C (fi) 1995-10-25
FI930723A (fi) 1993-02-18
WO1992004337A1 (en) 1992-03-19
JPH06500318A (ja) 1994-01-13
NZ239649A (en) 1994-04-27

Similar Documents

Publication Publication Date Title
EP0440950A3 (en) Halogenallyl-azolyl derivatives
HU912356D0 (en) Rapacmycine derivatives
EP0470466A3 (en) Halogenalkyl-azolyl derivatives
ZA914484B (en) Azolyl-propanol derivatives
ZA917003B (en) Novel thiazolidine derivatives
IL96819A0 (en) Azaoxindole derivatives
HRP930485A2 (en) Hiv-inhibiting benzenacetamide derivatives
IL99576A0 (en) Triazacyclohexane derivatives
EP0485984A3 (en) Diarylmethoxypiperidine derivatives
ZA914204B (en) Pyridinylpiperazine derivatives
GB9007569D0 (en) Carbo-nucleoside derivatives
NZ240693A (en) Oxazolidine derivatives
EP0440949A3 (en) Halogenallyl-azolyl derivatives
ZA914675B (en) 5-isothiazolamine derivatives
IL98897A0 (en) Carboxymethylcyclopropane derivatives
EP0453883A3 (en) 2-amino-4-trichloropyridine derivatives
ZA91419B (en) Thiazole derivatives
GB2249094B (en) Hetero-imidazodiazepine derivatives
GB9028059D0 (en) Thiazole derivatives
GB9003347D0 (en) Thiazole derivatives
GB9006772D0 (en) 4-piperidinyl-ergoline derivatives
EG19474A (en) Nitroenamine derivatives
EG19362A (en) Azoaxindole derivatives
GB9127530D0 (en) Thiazole derivatives
GB9025888D0 (en) Benzofuranyl-imidazole derivatives